Study suggested COVID-19 vaccines do not reduce fertility
On Feb. 8, 2022, a research team led at Boston University School of Public Health reported on links…
-
-
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
-
NIH-funded study found higher dose of DHA associated with lower early preterm birth rate
On May 24, 2021, scientists reported that women taking 1,000 mg of docosohexanoic acid (DHA) daily in the…
-
Research highlighted risks of separating newborns from mothers during COVID-19 pandemic
On Mar. 16, 2021, research from the World Health Organization (WHO) and partners showed that the COVID-19 pandemic…
-
Moderna announced participants dosed in phase 2/3 study of COVID-19 vaccine in pediatric population
On Mar. 16, 2021, Moderna announced that the first participants had been dosed in the Phase 2/3 study,…
-
COVID-19 | Diagnostics | Disease | NIH | Women's Health
Severe COVID-19 in pregnancy associated with preterm birth, other complications
On Jan. 28, 2021, National Institutes of Health (NIH) researchers reported that pregnant women who experienced severe symptoms…
-
Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages
On Jan. 25, 2021, the National Institutes of Health (NIH) announced that in large clinical trial conducted worldwide,…
-
Rising protocol design complexity reported driving rapid growth in clinical trial data volume
On Jan. 12, 2021, the Tufts Center for the Study of Drug Development (Tufts CSDD) reported that ever…
-
McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics of breast and ovarian cancer
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
-
ADHD risk may be linked to inflammation during pregnancy
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
-
Global study to assess effects of COVID-19 in pregnancy on mothers and babies was launched
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
-
Slower clearance of Coronavirus infection may explain why men fare worse than women
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
-
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
-
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
-
Newer anti-HIV drugs safest, most effective during pregnancy
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
-
NIHs Study found lower concentration of PrEP drug in young women during pregnancy than postpartum
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
-
First Swedish transplant of uterus from deceased donor
On Feb. 17, 2020, the University of Gothenburg announced that the team responsible for uterine transplantation research has,…
-
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
-
Penn Medicine birth marked a milestone in uterus transplant clinical trial
On Jan. 9, 2020, Penn Medicine announced the birth of Benjamin Thomas Gobrecht: his mother, 33-year-old Jennifer Gobrecht,…
-
Karmanos Cancer Institute received the 2020 Women’s Choice Award
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
-
The FDA approved new treatment option for patients with HER2-positive breast cancer
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
-
Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research
On Jan. 18, 2019, Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
-
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics | Women's Health
The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
-
Genetically modified babies given go ahead by UK ethics body
On Jul. 18, 2018, the Nuffield Council on Bioethics said that changing the DNA of a human embryo…
-
Biotechnology | Diagnostics | Disease | Medicine | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | Women's Health
The Stephenson Cancer Center received NCI designation
On May 2, 2018, the Stephenson Cancer Center received National Cancer Institute (NCI) designation. The Stephenson Cancer Center,…
-
CDC published summary of previously published ACIP recommendations for prevention of tetanus, diphtheria, and pertussis in the U.S.
On Apr. 27, 2018, the Centers for Disease Control and Prevention (CDC) published a comprehensive summary of previously…
-
The American College of Obstetricians and Gynecologists released opinion on influenza vaccination in pregnancy
On Apr. 1, 2018, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the…
-
Seattle Genetics acquired Cascadian Therapeutics
On Mar. 9, 2018, Seattle Genetics announced it had completed its acquisition of Cascadian Therapeutics for approximately $614…
-
FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
On Mar. 6, 2018, the U.S. Food and Drug Administration (FDA) authorized 23andMe’s Personal Genome Service Genetic Health…
-
The U.S. Surgeon General issued landmark Report on Alcohol, Drugs, and Health
On Nov. 17, 2016, the U.S. Surgeon General Dr. Vivek Murthy issued a landmark Report on Alcohol, Drugs,…
